Search research articles
Contact Us
Filters
Showing results (101-110 of 225) with videos related to
Page
of 23
Sort By:
The Journal of Antimicrobial Chemotherapy
|
April 14, 2011
Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus
Russell E Lewis, Guangling Liao, Jingguo Hou, et al.
Antimicrobial Agents and Chemotherapy
|
October 28, 2009
Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection
Ronen Ben-Ami, Russell E Lewis, Jeffrey Tarrand, et al.
Cells
|
August 28, 2024
Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria
Russell E Lewis, Marta Palombo, Erica Diani, et al.
Antimicrobial Agents and Chemotherapy
|
June 25, 2004
Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus
Wei Liu, Gregory S May, Michail S Lionakis, et al.
The Journal of Infection
|
July 7, 2009
A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response
Ronen Ben-Ami, Mario Luna, Russell E Lewis, et al.
The Journal of Antimicrobial Chemotherapy
|
February 4, 2003
Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species
Dimitrios P Kontoyiannis, Russell E Lewis, Nir Osherov, et al.
Antimicrobial Agents and Chemotherapy
|
January 24, 2008
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae
Georgios Chamilos, Russell E Lewis, Gregory A Lamaris, et al.
Antimicrobial Agents and Chemotherapy
|
June 24, 2015
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates
Nicholas D Beyda, Guangling Liao, Bradley T Endres, et al.
Diagnostic Microbiology and Infectious Disease
|
August 21, 2019
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis
Russell E Lewis, Sebastian Wurster, Nicholas D Beyda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 7, 2005
Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer
Georgios Chamilos, Edith M Marom, Russell E Lewis, et al.
Page
of 23
Search research articles
Search
Showing results (101-110 of 225) with videos related to
Sort By:
Page
of 23
The Journal of Antimicrobial Chemotherapy
|
April 14, 2011
Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus
Russell E Lewis, Guangling Liao, Jingguo Hou, et al.
Antimicrobial Agents and Chemotherapy
|
October 28, 2009
Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection
Ronen Ben-Ami, Russell E Lewis, Jeffrey Tarrand, et al.
Cells
|
August 28, 2024
Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria
Russell E Lewis, Marta Palombo, Erica Diani, et al.
Antimicrobial Agents and Chemotherapy
|
June 25, 2004
Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus
Wei Liu, Gregory S May, Michail S Lionakis, et al.
The Journal of Infection
|
July 7, 2009
A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response
Ronen Ben-Ami, Mario Luna, Russell E Lewis, et al.
The Journal of Antimicrobial Chemotherapy
|
February 4, 2003
Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species
Dimitrios P Kontoyiannis, Russell E Lewis, Nir Osherov, et al.
Antimicrobial Agents and Chemotherapy
|
January 24, 2008
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae
Georgios Chamilos, Russell E Lewis, Gregory A Lamaris, et al.
Antimicrobial Agents and Chemotherapy
|
June 24, 2015
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates
Nicholas D Beyda, Guangling Liao, Bradley T Endres, et al.
Diagnostic Microbiology and Infectious Disease
|
August 21, 2019
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis
Russell E Lewis, Sebastian Wurster, Nicholas D Beyda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 7, 2005
Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer
Georgios Chamilos, Edith M Marom, Russell E Lewis, et al.
Page
of 23